213753-76-5

Basic information

• Product Name: 7-Chloro-3-(2-hydroxy-ethyl)-1-methyl-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one
• Synonyms: 7-Chloro-3-(2-hydroxy-ethyl)-1-methyl-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one
• CAS NO: 213753-76-5
• Molecular Weight: 328.798
• Mol File: 213753-76-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 7-Chloro-3-(2-hydroxy-ethyl)-1-methyl-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 7-Chloro-3-(2-hydroxy-ethyl)-1-methyl-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one(213753-76-5)
• EPA Substance Registry System: 7-Chloro-3-(2-hydroxy-ethyl)-1-methyl-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one(213753-76-5)

Safety Data

• Hazardous Substances Data: 213753-76-5(Hazardous Substances Data)

Upstream product

• 213753-75-4 (7-Chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-acetic acid ethyl ester 
• 6021-21-2 2-(2-chloro-N-methyl-acetamido)-5-chlorobenzophenone 
• 1022-13-5 5-chloro-2-(methylamino)benzophenone 
• 439-14-5 diazepam 
• 75-21-8 oxirane 

Relevant articles and documents

COMPOSITIONS AND METHODS FOR REDUCING TACTILE DYSFUNCTION, ANXIETY, AND SOCIAL IMPAIRMENT

The present invention provides novel peripherally-restricted benzodiazepines with reduced blood brain barrier permeability and methods of use thereof for reducing tactile dysfunction, social impairment, and anxiety in a subject diagnosed with Autism Spectrum Disorder, Rett syndrome, Phelan McDermid syndrome, or Fragile X syndrome.